- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01957111
Metabolomics of Insomnia-Related Hyperarousal
November 14, 2016 updated by: University of Pennsylvania
Individuals with insomnia have been shown to have higher overall metabolic rates compared to good sleepers, but it is not known which metabolic processes are involved.
The goal of this study is to compare a wide array of metabolic processes in 15 people with insomnia and 15 good sleepers.
We hypothesize that there will be distinct metabolic processes that are functioning differently in those with insomnia.
Study Overview
Status
Completed
Conditions
Study Type
Observational
Enrollment (Actual)
32
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, United States, 19101
- University of Pennsylvania
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
25 years to 55 years (ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Individuals with primary insomnia (n=15) and matched good sleepers (n=15)
Description
Inclusion Criteria:
Criteria for primary insomnia:
- subjective complaint of difficulty initiating or maintaining sleep, waking up too early or nonrestorative sleep
- daytime consequences as a result of the poor sleep
- duration of at least 1 month
- sleep disturbance is not secondary to a medical or psychiatric condition
Criteria for good sleepers:
-subjective report of consistent good sleep
Exclusion Criteria:
- significant medical or psychiatric illness
- diagnosis of a sleep disorder other than insomnia
- women who have been pregnant or lactating in the past 6 months
- non-fluency in spoken or written English
- Current shift work defined as working during the evening or night shift
- Current use of medications that affect sleep
- BMI >27
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Individuals with insomnia
|
|
Good sleepers
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of Metabolites Elevated Relative to the Other Group.
Time Frame: 48 hours
|
Metabolomics analysis of blood samples were carried out using Spectroscopy.
This approach allows for rapid, unbiased and quantitative metabolic profiles ('fingerprints) to be acquired.
A total of 70 metabolites were measured and compared between individuals with insomnia and good sleepers.
|
48 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Sleep Efficiency Percentage on Overnight Sleep Study
Time Frame: 1 night
|
Participants will have their sleep measured with polysomnography for one night.
The sleep of individuals with insomnia will be compared to that of good sleepers.
Sleep quality is defined as sleep efficiency, which is calculated at total sleep time / total time spent in bed x 100.
It indicates the % of time spent asleep while in bed.
|
1 night
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2013
Primary Completion (ACTUAL)
October 1, 2015
Study Completion (ACTUAL)
October 1, 2015
Study Registration Dates
First Submitted
September 17, 2013
First Submitted That Met QC Criteria
October 7, 2013
First Posted (ESTIMATE)
October 8, 2013
Study Record Updates
Last Update Posted (ESTIMATE)
January 11, 2017
Last Update Submitted That Met QC Criteria
November 14, 2016
Last Verified
November 1, 2016
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- MISP-50802
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Primary Insomnia
-
Christoph NissenRecruitingInsomnia | Insomnia Chronic | Insomnia Disorder | Insomnia, Primary | Insomnia Type; Sleep Disorder | Insomnia Disorders | Insomnia, NonorganicSwitzerland
-
Midnight Pharma, LLCCompletedChronic Primary InsomniaUnited States
-
IWK Health CentreCompletedPrimary Insomnia | Nonorganic InsomniaCanada
-
University of UtahEvans Army Community HospitalCompletedPrimary Insomnia | Secondary InsomniaUnited States
-
Oregon Health and Science UniversityCompletedPrimary Insomnia | Psychophysiological InsomniaUnited States
-
University of RochesterSanofi-SynthelaboCompletedInsomnia | Primary Insomnia | Psychophysiologic InsomniaUnited States
-
University of WashingtonUnknownChronic Insomnia | Insomnia, Primary
-
US Department of Veterans AffairsCompletedInsomnia | Primary Insomnia | Secondary InsomniaUnited States
-
Jack Edinger, PhDMerck Sharp & Dohme LLCCompletedInsomnia | Primary Insomnia | Chronic InsomniaUnited States
-
University of PittsburghCompletedInsomnia Chronic | Insomnia, PrimaryUnited States